BioSpace News Archive

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced changes in the composition of its board of directors that will take effect later this year. Two of the Company’s directors will be leaving the board and, effective September 1, 2020, two new directors will be joining. The new board members are Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue,

Artio Medical, Inc. (Artio) today announced it has acquired Flow Forward Medical, Inc. (Flow Forward), a medical device company developing innovative methods for establishing and maintaining high-quality vascular access sites to improve outcomes for hemodialysis patients. This stock-for-stock merger transaction in which Flow Forward me

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D. will join the Company’s Board of Directors, effective September 1, 2020. In connection with the planned appointments, on September 1, 2020, Quotient will grant Dr. Buckle and Dr Larue each share options providing for the right to purch

Cerus Corporation (Nasdaq:CERS) announced today that its second quarter 2020 financial results will be released on Tuesday, August 4, 2020, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook. To listen to the live webcast and vi

- Apple‡ smartphone-compatible digital health tool fits within the company’s broader NeuroSphere™ Digital Care connected care management platform, which is designed to optimize care for chronic pain and movement disorders - NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered - Approval of the Patient Controller app is the latest launch under the NeuroSphere Digital Care(1) platform

EVERSANA™, the leading provider of global commercial services to the life sciences industry, announced a partnership with the Institute for Clinical and Economic Review to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments.

New research published in the European Journal of Nutrition finds that 100% orange juice reduces systolic blood pressure in adults with pre- or stage-1 hypertension

Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, announced the appointment of Rob Snow as Chief Sales Officer of Paradigm Complex Care Solutions, effective July 20th.

Sanford Health, the largest provider of rural healthcare in the country, today announced an $800,000 investment in TruGenomix, a veteran-owned precision behavioral health company. As part of the strategic partnership, Sanford Health will support Tru

Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2020 second quarter earnings investor webcast on Tues